< Back to search
Filter
1

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07594522

Phase1, Phase2, Recruiting

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

for
Oropharyngeal Squamous Cell Carcinoma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT04852328

Phase2, Recruiting

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

for
Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 50+

Code: NCT05556928

Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

for
B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins,
Location: Dallas TX, Sacramento CA
Sponsor: Estrella Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT06343311

Phase1, Phase2, Recruiting

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

for
B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL),
Location: New York NY, Philadelphia PA, Ottawa, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06526793

Phase2, Recruiting

Interested in new pancreatic cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Drug Screening Using Novel IMD in Renal Cell Carcinoma

for
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma,
Location: Boston MA
Sponsor: Oliver Jonas

Sex: All

Age: 18+

Code: NCT05700461

Phase1, Recruiting

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

for
Small Cell Lung Cancer, Renal Cell Carcinoma (RCC),
Location: Cleveland OH, Birmingham AL, St Louis MO
Sponsor: Advenchen Pharmaceuticals, LLC.

Sex: All

Age: 18+

Code: NCT05363280

Phase2, Recruiting

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT05052528

Phase1, Recruiting

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

for
Advanced Basal Cell Carcinoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05651828

Early_phase1, Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase3, Recruiting

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

for
Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC),
Location: Pittsburgh PA
Sponsor: Marissa Lobl

Sex: All

Age: 18+

Code: NCT07286318

Early_phase1, Recruiting

Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)

for
Diffuse Large B-cell Lymphoma
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18+

Code: NCT06977711

Phase1, Recruiting

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

for
Allogeneic Hematopoietic Stem Cell Transplantation,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18 - 70

Code: NCT06028828

Phase2, Recruiting

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04913311

Recruiting

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

for
Stage IV Esophageal Adenocarcinoma,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT04221893

Recruiting

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

for
RCC, Renal Cell Carcinoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT05931393

Phase2, Recruiting

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

for
Bile Duct Cancer, Gall Bladder Cancer, Breast Cancer,
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT05000294

Phase1, Phase2, Recruiting

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

for
Advanced Solid Tumor, Non-Small Cell Lung Cancer,
Location: Fairfax VA, Tampa FL, Sarasota FL
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07629960

Phase1, Phase2, Recruiting

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07510334

Phase2, Recruiting

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

for
Solid Tumor Malignancies, Testicular Cancer,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT07407582

Phase1, Phase2, Recruiting